These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 22194406)
1. US drug shortages are set to reach record high in 2011, report says. Tanne JH BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406 [No Abstract] [Full Text] [Related]
2. Pharmaceuticals and medical devices: cost savings. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
3. Pharmaceuticals and medical devices: business practices. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448 [No Abstract] [Full Text] [Related]
4. The right to a trial: Should dying patients have access to experimental drugs? Groopman J New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
6. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices. Moken MC Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247 [No Abstract] [Full Text] [Related]
7. Seizures of Canadian drugs rise as Congress, Customs spar. Carreyrou J Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501 [No Abstract] [Full Text] [Related]
9. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage? Roman A Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322 [No Abstract] [Full Text] [Related]
10. Safe drugs and the cost of good intentions. Eichler HG; Abadie E; Raine JM; Salmonson T N Engl J Med; 2009 Apr; 360(14):1378-80. PubMed ID: 19339718 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief. Health Policy Tracking Service, A Service of Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837 [No Abstract] [Full Text] [Related]
12. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
13. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
14. Report suggests steps to improve safety of drug supply. Traynor K Am J Health Syst Pharm; 2011 Sep; 68(17):1570, 1574. PubMed ID: 21856799 [No Abstract] [Full Text] [Related]
15. GMPs vs GCPs: manufacturing and compounding definitions. Allen LV Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778 [No Abstract] [Full Text] [Related]
16. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
17. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
18. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
19. FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages. Hunnisett-Dritz D Am J Health Syst Pharm; 2012 Oct; 69(19):1626, 1628. PubMed ID: 22997113 [No Abstract] [Full Text] [Related]
20. Pharmaceuticals: drug importation. Seay M; Jones TM Issue Brief Health Policy Track Serv; 2007 Jan; ():1-15. PubMed ID: 17361466 [No Abstract] [Full Text] [Related] [Next] [New Search]